AbbVie

March 24, 2017March 24, 2017

Galapagos Starts Trial of Therapy It Hopes Becomes Part of Triple-Combination CF Treatment

Cystic Fibrosis, News

Galapagos has started a Phase 1 clinical trial of its novel potentiator GLPG3067 for cystic fibrosis (CF). It is the second Phase 1 trial the company is conducting. The other one ... Read more

December 2, 2016December 2, 2016

Galapagos Begins Phase 1 Trial of Cystic Fibrosis Corrector in Healthy Volunteers

Cystic Fibrosis, News

Belgium-based Galapagos NV has started its Phase 1 clinical trial evaluating its novel C2 corrector GLPG2737 in healthy volunteers. The drug was developed as part of a triple combination therapy for ... Read more

May 17, 2016May 17, 2016

Galapagos Initiates Phase 1 Study of GLPG2451 for Cystic Fibrosis

Cystic Fibrosis, News

Galapagos NV recently announced the initiation of a phase 1 study investigating its compound GLPG2451 for the treatment of cystic fibrosis (CF). The molecule is the second compound in Galapagos’ extended CF-portfolio to ... Read more

May 4, 2016May 4, 2016

Galapagos, AbbVie Expand Collaboration on Cystic Fibrosis Treatments

Cystic Fibrosis, News

Galapagos NV and AbbVie are expanding their collaboration to continue their successful portfolio growth in cystic fibrosis (CF). The two companies are committed to increasing the potential milestones to Galapagos for Phase ... Read more

April 3, 2015November 5, 2015

AbbVie Opens Applications for CF Students Scholarship

Cystic Fibrosis, News

AbbVie has opened applications for its 2015 AbbVie CF Scholarship, a program dedicated to helping students who suffer from cystic fibrosis (CF) continue their education. Now through May 27th, undergraduate and ... Read more

December 26, 2014November 5, 2015

Galapagos Begins Phase I Study For Novel Cystic Fibrosis Therapy

Cystic Fibrosis, News

Developmental stage Galapagos NV is initiating its first phase 1 study to evaluate a CFTR targeted therapy for the treatment of cystic fibrosis (CF) called GLPG1837. The company is assessing a novel ... Read more